文献速递肝病

系统综述:布洛芬诱导的肝损伤

Systematic review: ibuprofen-induced liver injury.
PubMed 文献 · Aliment Pharmacol Ther · 2020-01-27

该系统综述检索已发表的病例系列和病例报告,分析布洛芬诱导肝损伤的临床、生化和结局特征。患者平均年龄31岁,55%为女性,平均累积剂量30g,潜伏期12天,肝细胞损伤型最常见,6例出现胆管消失综合征,11例完全恢复,5例进展为急性肝衰竭导致死亡或肝移植。

要点

  • 布洛芬相关药物性肝损伤常表现为短潜伏期后的肝细胞损伤型。
  • 文献报道布洛芬肝毒性可致急性肝衰竭、肝移植或死亡。
  • 布洛芬诱导肝损伤绝对风险低,仍可视为有效安全的非甾体抗炎药。

核心结论

  • 布洛芬与肝毒性相关,常表现为短潜伏期后的肝细胞损伤,虽有肝衰竭导致肝移植或死亡的报道,但绝对风险低,布洛芬仍可视为有效安全的非甾体抗炎药。

研究设计与样本

  • 系统检索已发表文献,分析病例系列和病例报告中布洛芬诱导肝损伤的人口学、临床、生化和结局数据。

主要发现

  • 患者平均年龄31岁,55%为女性,平均累积剂量30g,平均潜伏期12天。
  • 肝细胞损伤型是最常见的肝损伤模式,6例发生胆管消失综合征。
  • 11例在平均14周后完全恢复,5例进展为急性肝衰竭导致死亡或肝移植。

临床怎么用

  • 评估潜在肝毒性病例时,医生应考虑到文献中布洛芬与肝毒性的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are a leading cause of drug-induced liver injury (DILI) across the world. Ibuprofen is one of the most commonly used and safest NSAIDs, nevertheless reports on ibuprofen-induced hepatotoxicity are available. AIM: To analyse previously published information on ibuprofen-induced liver injury for a better characterisation of its phenotypic expression. METHOD: A systematic search was performed and information on ibuprofen-induced liver injury included in case series and case reports, in terms of demographic, clinical, biochemical and outcome data, was analysed. RESULTS: Twenty-two idiosyncratic ibuprofen hepatotoxicity cases were identified in the literature, suggesting a very low prevalence of this type of DILI. These patients had a mean age of 31 years and 55% were females. Mean cumulative dose of ibuprofen and time to onset were 30 g and 12 days, respectively. Hepatocellular injury was the most frequently involved liver injury pattern. Six cases developed vanishing bile duct syndrome. Full recovery occurred in 11 patients after a mean time of 14 weeks, whereas five cases evolved to acute liver failure leading to death/liver transplantation. CONCLUSIONS: When assessing potential hepatotoxicity cases, physicians should keep in mind that ibuprofen has been associated with hepatotoxicity in the literature. Ibuprofen-associated DILI presents commonly as hepatocellular damage after a short latency period. Published reports on ibuprofen hepatotoxicity leading to liver failure resulting in liver transplantation or death are available. However, due to the apparent low absolute risk of ibuprofen-induced liver complications, ibuprofen can be regarded as an efficacious and safe NSAID.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Zoubek ME, Lucena MI, Andrade RJ, et al. Systematic review: ibuprofen-induced liver injury. Aliment Pharmacol Ther. 2020. PMID: 31984540. doi:10.1111/apt.15645

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。